Novoprotein Scientific (688137.SS) Stock Price

Novoprotein Scientific Price

CLOSED
139.41
​
Market closed

Revenue has compounded at 26.3% per year over the past 6 years to 146.44 M CNY. Earnings per share have declined at 46.3% per year over the last 3 years. Novoprotein Scientific's net margin stands at -53.1%, down from 43.6% several years earlier. Novoprotein Scientific currently offers a dividend yield of about 0.36%.

Novoprotein Scientific stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Novoprotein Scientific business model & stock analysis

Novoprotein Scientific Inc, based in Suzhou, China, operates in the Health Care sector within Biotechnology. The company develops and sells recombinant protein solutions, including target and factor proteins, recombinant antibodies, enzymes, and reagents. Its products, such as novel coronavirus diagnostic antibodies and mRNA vaccine-related materials, serve biological medicine, life science research, in vitro diagnostics, and vaccine development. Employing 665 staff, Novoprotein serves domestic and international markets from its Suzhou headquarters.

Frequently asked questions about Novoprotein Scientific

5 analysts currently rate the Novoprotein Scientific stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Novoprotein Scientific share trades at 18.53 EUR (139.41 CNY).

The revenue cannot currently be calculated for Novoprotein Scientific.

The profit cannot currently be calculated for Novoprotein Scientific.

The P/E ratio cannot be calculated for Novoprotein Scientific at the moment.

The P/S cannot be calculated for Novoprotein Scientific currently.

The Eulerpool Quality Score for Novoprotein Scientific is 1/10.

The ISIN of Novoprotein Scientific is CNE100005NZ4. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Novoprotein Scientific is 688137.SS. The ticker symbol is used to trade Novoprotein Scientific shares on the stock exchange.

Fair ValueTerminal
135.23 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
220,209.77 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Sep 29, 2022
ISIN
CNE100005NZ4
Cusip
Y641EW108
Market capitalization
9.78 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
4.81
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-3.82 %
Dividend
Dividend yield
0.00 %
Payout Ratio
273.19 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Oct 17, 2026, 5:21 AM

Novoprotein Scientific Peer Group

Novoprotein Scientific FIGI

688137:CH · BBG0149RGLM3688137:CG · BBG0149RGLN2